查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1855935

2025年全球基於次世代定序儀（NGS）的分子診斷市場報告

Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，基於次世代定序儀（NGS）的分子診斷市場規模呈現強勁成長，從2024年的21億美元成長到2025年的22.6億美元，複合年成長率（CAGR）為7.8%。這一成長主要歸因於對個性化醫療需求的不斷成長、次世代定序儀在臨床環境中的廣泛應用、臨床醫生和患者意識的提高、經濟高效的NGS平台的日益普及以及無創產前檢測應用的不斷擴展。

預計未來幾年，基於次世代定序儀(NGS) 的分子診斷市場將保持強勁成長，到 2029 年市場規模將達到 30.1 億美元，複合年成長率 (CAGR) 為 7.4%。預測期內的成長主要受以下因素驅動：對分散式診斷解決方案的需求不斷成長、人工智慧在 NGS 數據解讀中的應用日益廣泛、抗生素抗藥性問題日益嚴峻、監管機構對基於 NGS 的檢測方法的支持力度不斷加大，以及 NGS 在藥物基因組學領域的應用日益普及。預測期內的關鍵趨勢包括：定序準確性的提高、樣本製備技術的主導、與藥物開發平臺的整合、NGS 在公共衛生監測中的應用，以及疾病特異性NGS 檢測組合的開發。

預計未來幾年，感染疾病的日益普及將推動基於次世代定序儀（NGS）的分子診斷市場成長。感染疾病是由細菌、病毒、真菌和寄生蟲等微生物引起的，這些微生物侵入人體、繁殖並破壞正常功能。全球旅行和人口流動的增加促進了病原體在不同地區和國界之間的傳播，從而導致感染疾病病例的增加。基於NGS的分子診斷技術透過對病原體進行全面、精確的分析，並能夠同時識別多種微生物，從而縮短診斷時間，提高治療準確性和患者照護，進而幫助檢測這些疾病。例如，英國衛生安全局在2024年2月報告稱，英格蘭的結核病病例增加了10.7%，從2022年的4380例增加到2023年的4850例。因此，感染疾病的日益普及正在推動對基於NGS的分子診斷技術的需求。

基於新一代定序（NGS）的分子診斷市場的主要參與者正在開發先進產品，例如靶向NGS panel，以提高基因檢測的準確性、可及性和效率。這些NGS panel可同時分析特定基因或基因組區域，快速且準確地檢測遺傳性和體細胞突變。例如，2022年5月，印度醫療設備製造商Genes2Me Pvt. Ltd.推出了一系列全面的NGS panel，旨在用於腫瘤學、個人化醫療和遺傳疾病診斷。這些panel涵蓋了具有高靈敏度的臨床重要基因，並可檢測多種基因組改變，包括單核苷酸突變、插入/缺失、拷貝數變異、微衛星不穩定性、融合、致癌性病毒和腫瘤突變負荷。該公司推出的PAN癌症panel靶向約525個基因，僅需50 ng核酸，並支援與主流NGS平台相容的簡化工作流程。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球主題關鍵字：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 終端用戶產業分析
  • 全球基於次世代定序儀（NGS）的分子診斷市場：成長率分析
  • 全球基於次世代定序儀（NGS）的分子診斷市場表現：規模與成長，2019-2024年
  • 全球基於次世代定序儀（NGS）的分子診斷市場預測：規模與成長，2024-2029年，2034年預測
  • 全球主題關鍵字：總潛在市場規模 (TAM)

第6章 市場細分

  • 全球基於次世代定序儀(NGS) 的分子診斷市場：按類型、實際結果和預測（2019-2024 年、2024-2029 年預測、2034 年預測）
  • 裝置
  • 試劑和耗材
  • 軟體和服務
  • 檢測組和檢測方法
  • 樣品製備試劑盒
  • 全球基於次世代定序儀(NGS) 的分子診斷市場：按應用領域分類，實際結果與預測，2019-2024 年、2024-2029 年預測、2034 年預測
  • 微生物學
  • 感染疾病
  • 腫瘤學
  • 基因檢測
  • 其他用途
  • 全球基於次世代定序儀(NGS) 的分子診斷市場：依最終使用者分類，實際值與預測值，2019-2024 年、2024-2029 年預測值、2034 年預測值
  • 研究中心和學術機構
  • 醫院和臨床檢查室
  • 其他最終用戶
  • 全球基於次世代定序儀(NGS) 的分子診斷市場：按設備、類型、實際值和預測值細分，2019-2024 年、2024-2029 年預測值、2034 年預測值
  • 桌上型音序器
  • 高通量定序儀
  • 可攜式或手持式音序器
  • 臨床或診斷定序儀
  • 自動化文庫製備系統
  • 數據分析和生物資訊硬體
  • 全球基於次世代定序儀(NGS) 的分子診斷市場：按試劑和耗材、類型細分，實際值和預測值（2019-2024 年、2024-2029 年預測值、2034 年預測值）。
  • 定序試劑和試劑盒
  • 文庫製備試劑
  • 靶向序列捕獲試劑
  • 擴增試劑
  • 定序流動池和晶片
  • 去氧核糖核酸(DNA) 或核糖核酸 (RNA) 萃取試劑
  • 品管試劑
  • 全球基於次世代定序儀(NGS) 的分子診斷市場：按軟體和服務、類型細分，實際值和預測值（2019-2024 年、2024-2029 年預測值、2034 年預測值）。
  • 數據分析軟體
  • 生物資訊流程
  • 雲端基礎的基因組學平台
  • 臨床解讀工具
  • 資料儲存和管理服務
  • 客製化生物資訊學服務
  • 基因組資料庫服務
  • 全球基於次世代定序儀(NGS) 的分子診斷市場：按檢測組合和檢測方法、類型細分，實際值和預測值（2019-2024 年、2024-2029 年預測值、2034 年預測值）。
  • 腫瘤專家組
  • 感染疾病專家組
  • 攜帶者篩檢小組
  • 生殖健康小組
  • 罕見疾病或遺傳疾病檢測組合
  • 藥物基因體學組學分析組
  • 全EXOME或全基因組檢測
  • 全球基於次世代定序儀(NGS) 的分子診斷市場：按樣本製備試劑盒、類型、實際值和預測值分類的細分市場，2019-2024 年、2024-2029 年預測值、2034 年預測值
  • 去氧核糖核酸(DNA) 萃取試劑盒
  • 核糖核酸（RNA）萃取試劑盒
  • 圖書館準備工具包
  • 標靶富集試劑盒
  • 擴增淨化試劑盒
  • 單細胞製備試劑盒
  • 低投入量或劣化樣品試劑盒

第7章 區域和國家分析

  • 全球基於次世代定序儀（NGS）的分子診斷市場：區域分析、預測與成長，2019-2024年、2024-2029年預測、2034年預測
  • 全球基於次世代定序儀(NGS) 的分子診斷市場：國家/地區、績效及預測，2019-2024 年、2024-2029 年預測、2034 年預測

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 基於次世代定序儀（NGS）的分子診斷市場：競爭格局
  • 基於次世代定序儀（NGS）的分子診斷市場：公司概況
    • Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • Amoy Diagnostics Co. Ltd.
  • Tempus Labs Inc.
  • Myriad Genetics Inc.
  • Epigenomics AG
  • Precision for Medicine Inc.
  • Invitae Corporation
  • NeoGenomics Laboratories Inc.
  • Guardant Health Inc.
  • Caris Life Sciences Inc.
  • Foundation Medicine Inc.
  • Oxford Nanopore Technologies Ltd.
  • Freenome Inc.
  • Burning Rock Biotech

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年基於次世代定序儀（NGS）的分子診斷市場：提供新機會的國家
  • 2029年基於次世代定序儀（NGS）的分子診斷市場：提供新機會的細分市場
  • 2029年基於次世代定序儀（NGS）的分子診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38587

Next-generation sequencing (NGS)-based molecular diagnostics is a technology-driven approach that uses high-throughput sequencing to analyze genetic material with precision and speed. It enables detection of genetic variations, mutations, and disease markers at the molecular level, providing detailed insights into the genetic basis of health and disease. This approach supports precise, data-driven diagnostics by combining sequencing technologies with advanced bioinformatics.

The primary types of NGS-based molecular diagnostics include instruments, reagents and consumables, software and services, panels and assays, and sample preparation kits. NGS instruments are the hardware platforms, such as sequencers and automation workstations, used to perform high-throughput DNA/RNA sequencing. Applications include microbiology, infectious diseases, oncology, genetic testing, and other areas. End users include research centers, academic institutions, hospitals, clinical laboratories, and other organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The next-generation sequencing (NGS) based molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides next-generation sequencing (NGS) based molecular diagnostics market statistics, including next-generation sequencing (NGS) based molecular diagnostics industry global market size, regional shares, competitors with a next-generation sequencing (NGS) based molecular diagnostics market share, detailed next-generation sequencing (NGS) based molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation sequencing (NGS) based molecular diagnostics industry. The next-generation sequencing (NGS)-based molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The next-generation sequencing (NGS)-based molecular diagnostics market size has grown strongly in recent years. It will grow from $2.10 billion in 2024 to $2.26 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth during the historic period is linked to increasing demand for personalized medicine, wider adoption of next-generation sequencing in clinical settings, growing awareness among clinicians and patients, greater availability of cost-effective NGS platforms, and expanding applications in non-invasive prenatal testing.

The next-generation sequencing (NGS)-based molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.01 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth projected for the forecast period is driven by rising demand for decentralized diagnostic solutions, increasing use of artificial intelligence in NGS data interpretation, growing burden of antibiotic resistance, enhanced regulatory support for NGS-based tests, and greater utilization of NGS in pharmacogenomics. Primary trends during the forecast period include advancements in sequencing accuracy, technology-driven automation in sample preparation, integration with pharmaceutical development pipelines, incorporation of NGS into public health surveillance, and development of disease-specific NGS panels.

The rising incidence of infectious diseases is expected to drive growth in the next-generation sequencing (NGS)-based molecular diagnostics market in the coming years. Infectious diseases are illnesses caused by microorganisms such as bacteria, viruses, fungi, or parasites that invade and multiply within the body, disrupting normal functions. Increasing global travel and migration contribute to the spread of pathogens across regions and borders, fueling the rise in infectious disease cases. NGS-based molecular diagnostics aids in detecting these diseases by offering comprehensive and precise analysis of pathogens, enabling simultaneous identification of multiple microorganisms, which shortens diagnostic time and improves treatment accuracy and patient care. For example, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England increased by 10.7%, rising from 4,380 in 2022 to 4,850 in 2023. Consequently, the growing incidence of infectious diseases is propelling the demand for NGS-based molecular diagnostics.

Key players in the NGS-based molecular diagnostics market are developing advanced products such as targeted NGS panels to improve the accuracy, accessibility, and efficiency of genetic testing. These NGS panels analyze specific genes or genomic regions simultaneously to detect hereditary or somatic mutations quickly and accurately. For instance, in May 2022, Genes2Me Pvt. Ltd., an Indian medical equipment manufacturer, introduced a comprehensive series of NGS panels aimed at oncology, personalized medicine, and hereditary disease diagnostics. These panels cover clinically significant genes with high sensitivity and detect various genomic alterations, including single-nucleotide variants, insertions/deletions, copy number variations, microsatellite instability, fusions, oncogenic viruses, and tumor mutation burden. Their PAN cancer panel targets about 525 genes, requiring only 50 ng of nucleic acid, and supports streamlined workflows compatible with major NGS platforms.

In January 2023, QIAGEN NV, a molecular diagnostics and life sciences company based in Germany, acquired Verogen Inc. for an undisclosed sum. This acquisition aims to enhance QIAGEN's leadership in human identification and forensic genomics by integrating Verogen's specialized NGS technologies into its broader molecular diagnostics portfolio. This expansion strengthens QIAGEN's presence in public sector forensics and private sector applications such as genetic genealogy. Verogen Inc. is a US-based company specializing in NGS solutions for forensic genomics.

Major players in the next-generation sequencing (NGS)-based molecular diagnostics market are Thermo Fisher Scientific, Siemens Healthineers AG, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Amoy Diagnostics Co. Ltd., Tempus Labs Inc., Myriad Genetics Inc., Epigenomics AG, Precision for Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Caris Life Sciences Inc., Foundation Medicine Inc., Oxford Nanopore Technologies Ltd., Freenome Inc., Burning Rock Biotech, Element Biosciences Inc., Asuragen Inc., Bionano Genomics Inc., Genomic Health Inc., and TATAA Biocenter AB.

North America was the largest region in the next-generation sequencing (NGS)-based molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in next-generation sequencing (NGS)-based molecular diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the next-generation sequencing (NGS)-based molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The next-generation sequencing (NGS)-based molecular diagnostics market includes revenues earned by entities by providing services, such as clinical genomic testing, cancer genomic profiling, infectious disease detection, liquid biopsy testing, and pharmacogenomics testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation sequencing (NGS)-based molecular diagnostics market also includes sales of tumor mutation panels, carrier screening kits, drug response panels, companion diagnostic kits, and whole-genome metagenomics kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on next-generation sequencing (ngs)-based molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for next-generation sequencing (ngs)-based molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The next-generation sequencing (ngs)-based molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Instruments; Reagents And Consumables; Software And Services; Panels And Assays; Sample Preparation Kits
  • 2) By Application: Microbiology; Infectious Diseases; Oncology; Genetic Tests; Other Applications
  • 3) By End User: Research Centers And Academics; Hospitals And Clinical Laboratories; Other End Users
  • Subsegments:
  • 1) By Instruments: Benchtop Sequencers; High-Throughput Sequencers; Portable Or Handheld Sequencers; Clinical Or Diagnostic Sequencers; Automated Library Preparation Systems; Data Analysis And Bioinformatics Hardware
  • 2) By Reagents And Consumables: Sequencing Reagents And Kits; Library Preparation Reagents; Target Enrichment Reagents; Amplification Reagents; Sequencing Flow Cells And Chips; Deoxyribonucleic Acid (DNA) Or Ribonucleic Acid (RNA) Extraction Reagents; Quality Control Reagents
  • 3) By Software And Services: Data Analysis Software; Bioinformatics Pipelines; Cloud-Based Genomic Platforms; Clinical Interpretation Tools; Data Storage And Management Services; Custom Bioinformatics Services; Genomic Database Services
  • 4) By Panels And Assays: Oncology Panels; Infectious Disease Panels; Carrier Screening Panels; Reproductive Health Panels; Rare Disease Or Genetic Disorder Panels; Pharmacogenomics Panels; Whole-Exome Or Whole-Genome Assays
  • 5) By Sample Preparation Kits: Deoxyribonucleic Acid (DNA) Extraction Kits; Ribonucleic Acid (RNA) Extraction Kits; Library Preparation Kits; Target Enrichment Kits; Amplification And Cleanup Kits; Single-Cell Preparation Kits; Low-Input Or Degraded Sample Kits
  • Companies Mentioned: Thermo Fisher Scientific; Siemens Healthineers AG; Agilent Technologies Inc.; Illumina Inc.; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Qiagen N.V.; Amoy Diagnostics Co. Ltd.; Tempus Labs Inc.; Myriad Genetics Inc.; Epigenomics AG; Precision for Medicine Inc.; Invitae Corporation; NeoGenomics Laboratories Inc.; Guardant Health Inc.; Caris Life Sciences Inc.; Foundation Medicine Inc.; Oxford Nanopore Technologies Ltd.; Freenome Inc.; Burning Rock Biotech; Element Biosciences Inc.; Asuragen Inc.; Bionano Genomics Inc.; Genomic Health Inc.; TATAA Biocenter AB
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Characteristics

3. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Trends And Strategies

4. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Growth Rate Analysis
  • 5.4. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Total Addressable Market (TAM)

6. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Segmentation

  • 6.1. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagents And Consumables
  • Software And Services
  • Panels And Assays
  • Sample Preparation Kits
  • 6.2. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microbiology
  • Infectious Diseases
  • Oncology
  • Genetic Tests
  • Other Applications
  • 6.3. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research Centres And Academics
  • Hospitals And Clinical Laboratories
  • Other End Users
  • 6.4. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Benchtop Sequencers
  • High-Throughput Sequencers
  • Portable Or Handheld Sequencers
  • Clinical Or Diagnostic Sequencers
  • Automated Library Preparation Systems
  • Data Analysis And Bioinformatics Hardware
  • 6.5. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing Reagents And Kits
  • Library Preparation Reagents
  • Target Enrichment Reagents
  • Amplification Reagents
  • Sequencing Flow Cells And Chips
  • Deoxyribonucleic Acid (DNA) Or Ribonucleic Acid (RNA) Extraction Reagents
  • Quality Control Reagents
  • 6.6. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Software
  • Bioinformatics Pipelines
  • Cloud-Based Genomic Platforms
  • Clinical Interpretation Tools
  • Data Storage And Management Services
  • Custom Bioinformatics Services
  • Genomic Database Services
  • 6.7. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Sub-Segmentation Of Panels And Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology Panels
  • Infectious Disease Panels
  • Carrier Screening Panels
  • Reproductive Health Panels
  • Rare Disease Or Genetic Disorder Panels
  • Pharmacogenomics Panels
  • Whole-Exome Or Whole-Genome Assays
  • 6.8. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Sub-Segmentation Of Sample Preparation Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deoxyribonucleic Acid (DNA) Extraction Kits
  • Ribonucleic Acid (RNA) Extraction Kits
  • Library Preparation Kits
  • Target Enrichment Kits
  • Amplification And Cleanup Kits
  • Single-Cell Preparation Kits
  • Low-Input Or Degraded Sample Kits

7. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Regional And Country Analysis

  • 7.1. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 8.1. Asia-Pacific Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 9.1. China Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 9.2. China Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 10.1. India Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 11.1. Japan Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 11.2. Japan Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 12.1. Australia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 13.1. Indonesia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 14.1. South Korea Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 14.2. South Korea Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 15.1. Western Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 15.2. Western Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 16.1. UK Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 17.1. Germany Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 18.1. France Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 19.1. Italy Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 20.1. Spain Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 21.1. Eastern Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 21.2. Eastern Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 22.1. Russia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 23.1. North America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 23.2. North America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 24.1. USA Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 24.2. USA Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 25.1. Canada Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 25.2. Canada Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 26.1. South America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 26.2. South America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 27.1. Brazil Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 28.1. Middle East Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 28.2. Middle East Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

  • 29.1. Africa Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Overview
  • 29.2. Africa Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Competitive Landscape
  • 30.2. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Other Major And Innovative Companies

  • 31.1. Bio-Rad Laboratories Inc.
  • 31.2. Qiagen N.V.
  • 31.3. Amoy Diagnostics Co. Ltd.
  • 31.4. Tempus Labs Inc.
  • 31.5. Myriad Genetics Inc.
  • 31.6. Epigenomics AG
  • 31.7. Precision for Medicine Inc.
  • 31.8. Invitae Corporation
  • 31.9. NeoGenomics Laboratories Inc.
  • 31.10. Guardant Health Inc.
  • 31.11. Caris Life Sciences Inc.
  • 31.12. Foundation Medicine Inc.
  • 31.13. Oxford Nanopore Technologies Ltd.
  • 31.14. Freenome Inc.
  • 31.15. Burning Rock Biotech

32. Global Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

34. Recent Developments In The Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market

35. Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer